Study On The Development Strategy Of Sheng Yin Pharmaceutical Group

The pharmaceutical industry is one of the fastest growing sunrise industries in the world trade.With the rapid development of our economy and the improvement of people's living standards,our pharmaceutical industry has maintained a stable and rapid development trend.Especially with the deepening of the reform of the medical and health system in recent years and the comprehensive implementation of the Healthy China 2030 Strategy,the industrial upgrading of pharmaceutical enterprises has injected new impetus into the development of the pharmaceutical industry.However,while the reform of the medical and health system has brought new opportunities for the development of the pharmaceutical industry,it has also brought severe challenges.Since 2018,with the continuous standardization of China's drug supervision and management,under the influence of policies such as the adjustment and optimization of the medical insurance catalogue,the "two-vote system",the consistency evaluation of the quality and efficacy of generic drugs,and the "4 + 7" quantity procurement,etc.The market is gradually developing towards large-scale and centralized development.The R & D costs of pharmaceutical companies have increased,and most of them have been impacted.The production kinetic energy has declined,and the growth rate of industrial added value has slowed down.In the face of these new challenges and opportunities,many domestic pharmaceutical companies are struggling to adapt to the new industry environment by continuously optimizing their development strategies in combination with their existing products and market needs.Established in 1990,Sheng yin Pharmaceutical Group is one of the earliest listed pharmaceutical companies in the country.It is a comprehensive pharmaceutical company integrating drug production,sales and research and development.However,facing the international and domestic pharmaceutical industry trends,like many pharmaceutical companies,enterprises are also facing a lot of strategic management issues,such as optimizing talent structure,adjusting product structure,controlling production costs and increasing profit margins.Therefore,this article takes Sheng yin Pharmaceutical Group as the research object,through field investigation and analysis,summarizes the current situation,corporate strategic management's problems and reasons,and based on the theory of strategic management,puts forward a suitable development strategy and concrete measures for business.Firstly,the general situation of Sheng yin Pharmaceutical Group was introduced,and evaluated its development status.Secondly,the problems and causes of the development of Sheng yin Pharmaceutical Group were analyzed.Thirdly,it analyzes the internal and external development environment of Sheng yin Pharmaceutical Group,and summarizes the advantages,disadvantages,opportunities,and threats of the company.Finally,the strategic goals,development strategies and guarantee measures for the implementation of the development strategy of Sheng yin Pharmaceutical Group are put forward.This article believes that Sheng yin Pharmaceutical Group should formulate a development strategy based on a cost-leading strategy and a strengthened strategy as the core,effectively strengthen product research and development,continuously improve product technology content,reduce procurement costs,and continuously optimize product quality control standards.Continuously promote the refined management of production and various equipment,strengthen marketing efforts,improve the professional level of marketers,improve the management mechanism,further improve the management level of the enterprise,adapt to the situation,comprehensively transform,and strive to achieve the company's "new development,new Across."...